|
65
|
200
|
5lf1K |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
69
|
244
|
5l5yB |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with carfilzomib |
|
69
|
244
|
5l69B |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
67
|
233
|
5l61M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
67
|
233
|
5l60M |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with pr-924 |
|
68
|
213
|
5lf1L |
Human 20s proteasome complex with dihydroeponemycin at 2.0 angstrom |
|
59
|
226
|
5l68H |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
67
|
242
|
5m2bD |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
56
|
202
|
5lezN |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
58
|
226
|
5l64H |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
66
|
250
|
5l5zA |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
66
|
230
|
5lezA |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
59
|
196
|
5l67N |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with pr-924 |
|
67
|
242
|
5l69D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
60
|
195
|
5lttJ |
Yeast 20s proteasome with human beta5i (1-138; r57t)in complex with pr-924 |
|
63
|
231
|
5l6cE |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
61
|
222
|
5l64L |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
64
|
211
|
5l6bK |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
69
|
243
|
5l5tF |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
73
|
248
|
5lezB |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
66
|
250
|
5l62A |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 16 |
|
65
|
200
|
5lf4K |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
62
|
237
|
5lezC |
Human 20s proteasome complex with oprozomib in mg-acetate at 2.2 angstrom |
|
60
|
195
|
5l68J |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 14 |
|
151
|
398
|
5lldA |
Flavodiiron core of escherichia coli flavorubredoxin in the reduced form. |
|
69
|
240
|
5l5rC |
Yeast 20s proteasome with human beta5i (1-138;v31m) and human beta6 (97-111; 118-133) |
|
61
|
222
|
5l5uL |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
67
|
242
|
5l6cD |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 18 |
|
57
|
204
|
5le5I |
Native human 20s proteasome at 1.8 angstrom |
|
55
|
202
|
5lf3N |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
66
|
230
|
5lf6A |
Human 20s proteasome complex with z-lly-ketoaldehyde at 2.1 angstrom |
|
60
|
226
|
5l6bH |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with onx 0914 |
|
70
|
243
|
5l5xF |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
58
|
204
|
5l5zI |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
|
66
|
216
|
5leyM |
Human 20s proteasome complex with oprozomib at 1.9 angstrom |
|
54
|
204
|
5lf7I |
Human 20s proteasome complex with ixazomib at 2.0 angstrom |
|
70
|
243
|
5l6aF |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
64
|
241
|
5l5xG |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
68
|
211
|
5l61K |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone inhibitor 14 |
|
54
|
204
|
5lf4I |
Human 20s proteasome complex with delanzomib at 2.0 angstrom |
|
59
|
195
|
5l6aJ |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
59
|
226
|
5m2bH |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with thiazole based inhibitor ro19 |
|
65
|
200
|
5lexK |
Native human 20s proteasome in mg-acetate at 2.2 angstrom |
|
62
|
233
|
5lf3D |
Human 20s proteasome complex with bortezomib at 2.1 angstrom |
|
70
|
242
|
5l65D |
Yeast 20s proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with carfilzomib |
|
66
|
250
|
5l5uA |
Yeast 20s proteasome with human beta5i (1-138; v31m) and human beta6 (97-111; 118-133) in complex with epoxyketone inhibitor 17 |
|
65
|
231
|
5l5dE |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
58
|
196
|
5l5xN |
Yeast 20s proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with onx 0914 |
|
62
|
211
|
5l5aK |
Yeast 20s proteasome with human beta5i (1-138; r57t) |
|
60
|
196
|
5l5fN |
Yeast 20s proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bortezomib |
